medical supply manufacturing and distribution, which increased from the same period of the previous year for 4.80 million baht or 18.99%, resulting in the increase of the Company Group’s gross profit for
December 31, CONSOLIDATED Change (BAHT'000) 2017 2016 Amount % Interest income 14,844,465 14,869,138 (24,673) (0.2) Interest expenses 4,216,027 4,436,088 (220,061) (5.0) Interest income, net 10,628,438
year ended December 31, CONSOLIDATED Change (BAHT'000) 2017 2016 Amount % Interest income 14,844,465 14,869,138 (24,673) (0.2) Interest expenses 4,216,027 4,436,088 (220,061) (5.0) Interest income, net
. Significant Changes การเปลี่ยนแปลงที่สําคัญ I X. THE OFFER AND LISTING A. Offer and Listing Details รายละเอียดเก่ียวกับการเสนอขายและจดทะเบียนหลักทรัพย B. Plan of Distribution แผนการจัดจําหนายหลักทรัพย C
OPERATION (Unit : Million Baht) Consolidated Financial Statements 2019 2018 % Change Total Revenue 1,857.2 1,708.3 8.7% - Utilities Business 1,847.1 1,705.1 8.3% - Operating Revenue1 1,734.3 1,679.7 3.3
days 69 72 63 Cash Conversion Cycle days 81 75 66 Finanial data and profitability ratios Sales revenues million baht 49,269 46,887 46,938 %change (%) 5.1% (0.11%) 6.51% Gross profit million baht 12,547
OPERATION (Unit : Million Baht) Consolidated Financial Statements 2019 2018 % Change Total Revenue 1,857.2 1,708.3 8.7% - Utilities Business 1,847.1 1,705.1 8.3% - Operating Revenue1 1,734.3 1,679.7 3.3
statement ended 30th Sept ended 30th Sept July - Sept 2020 July - Sept 2019 Change % Change Apr - Sept 2020 Apr - Sept 2019 Change % Change Revenue from sales & service 518.91 745.69 -226.78 -30.4% 930.49
Discussion & Analysis Q1/2022 Operating Highlights in Q1/2022 Q1/21 Q1/22 Change +/(-) (THB million) %YoY Operating Revenue 179 198 11% Gross Profit 105 120 14% EBITDA 57 58 2% Net Profit (Loss) for the
the Company in Q1/2023 Q1/22 Q1/23 Change +/(-) (THB million) %YoY Operating Revenue 198 264 33% Cost of Sales (78) (96) (23%) Gross Profit 120 168 40% Other income 3 4 33% Selling and Distribution